Teva Pharmaceutical Industries has published its Q2 2026 Aide Memoire, a document compiling public information to assist investors before the company's second quarter earnings release on July 29, 2026. The report includes prior results, management commentary, and independent data, providing insight into Teva's business outlook. Following the earnings release at 7:00 a.m. ET, a conference call will be held at 8:00 a.m. ET to discuss the results. This update is part of Teva's ongoing communication with investors as it continues transforming into a leading biopharmaceutical company.
Alamos Gold reported operational challenges at its Young-Davidson mine, including seismic events and power outages, leading to lower production and higher costs in Q2 2026. The company now expects second quarter production between 130,000 and 135,000...
Churchill Downs Incorporated announced that the State of Maryland intends to exercise its legal right to acquire the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes by matching Churchill Downs' $85 million purchase of...
The State of Maryland has decided to exercise its legal right to acquire the intellectual property rights for the Preakness Stakes and Black-Eyed Susan Stakes by matching Churchill Downs Incorporated's $85 million purchase offer. This move means Mary...
ATN International announced a 5.5% increase in its quarterly cash dividend, raising it from $0.275 to $0.29 per share. The dividend will be paid on July 8, 2026, to shareholders of record as of June 30, 2026. This marks a continuation of ATN's divide...
Carnival Corporation's stock surged following a US-Iran memorandum of understanding to end hostilities and reopen the Strait of Hormuz, allowing Iranian oil exports to resume. This deal led to a drop in oil prices, with West Texas Intermediate fallin...
